TrademarkOpen
Search / United States / 98327605

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the countries listed. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark

REZDIFFRA

Registered
Used for: Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis

Class 5 – Pharmaceuticals & supplements

Status timeline

  1. 22 Dec 2023
    Application filed
    Nwap
  2. 24 Jul 2024
    Assigned to an examining attorney
    Dock
  3. 24 Jul 2024
    Approved for publication
    Cnsa
  4. 27 Aug 2024
    Published for opposition
    Pubo
  5. 22 Oct 2024
    Notice of allowance issued — statement of use required
    Noam
  6. 18 Apr 2025
    Statement of use filed
    Eisu
  7. 9 Sep 2025
    Statement of use accepted
    Cnpr
  8. 30 Sep 2025
    Registered on the Principal Register
    R.pr
All 16 events
2025-09-30R.pr
2025-09-30Nrcc
2025-09-09Cnpr
2025-09-09Suna
2025-09-07Supc
2025-09-05Aitu
2025-04-18Eisu
2025-04-18Iuaf
2024-10-22Noam
2024-08-27Pubo
2024-08-27Npub
2024-08-07Nonp
2024-07-24Dock
2024-07-24Cnsa
2024-04-04Nwos
2023-12-22Nwap

Goods & services by class

Class 5 Pharmaceuticals & supplements

Pharmaceutical preparations for the treatment of patients with non-alcoholic steatohepatitis (NASH) with liver fibrosis

First use anywhere 14 Mar 2024 · First use in commerce 14 Mar 2024

Source & freshness

Source: the official United States trademark register. This record was last updated on 30 Sep 2025; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.